Market closedNon-fractional
Inari Medical/NARI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Inari Medical
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.
Ticker
NARI
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Irvine, United States
Employees
1,300
Website
www.inarimedical.com
Inari Medical Metrics
BasicAdvanced
$3.2B
Market cap
-
P/E ratio
-$0.41
EPS
0.85
Beta
-
Dividend rate
Price and volume
Market cap
$3.2B
Beta
0.85
Financial strength
Current ratio
2.712
Quick ratio
2.091
Long term debt to equity
6.657
Total debt to equity
7.042
Interest coverage (TTM)
-27.30%
Management effectiveness
Return on assets (TTM)
-0.68%
Return on equity (TTM)
-5.41%
Valuation
Price to revenue (TTM)
6.103
Price to book
7.18
Price to tangible book (TTM)
34.95
Price to free cash flow (TTM)
171.719
Growth
Revenue change (TTM)
26.10%
Earnings per share change (TTM)
-21.42%
3-year revenue growth (CAGR)
45.19%
3-year earnings per share growth (CAGR)
9.50%
What the Analysts think about Inari Medical
Analyst Ratings
Majority rating from 11 analysts.
Inari Medical Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$143M
8.41%
Net income
-$24M
426.09%
Profit margin
-16.91%
385.92%
Inari Medical Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.04
$0.05
-$0.08
-$0.22
-
Expected
-$0.13
$0.00
$0.01
-$0.20
-$0.14
Surprise
-131.63%
1,025.11%
-1,433.33%
9.93%
-
Inari Medical News
AllArticlesVideos
Inari Medical to Announce Second Quarter 2024 Financial Results
GlobeNewsWire·1 week ago
Inari Medical, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 12, 2024 to Discuss Your Rights - NARI
Accesswire·2 weeks ago
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Inari Medical, Inc. – NARI
GlobeNewsWire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Inari Medical stock?
Inari Medical (NARI) has a market cap of $3.2B as of July 27, 2024.
What is the P/E ratio for Inari Medical stock?
The price to earnings (P/E) ratio for Inari Medical (NARI) stock is 0 as of July 27, 2024.
Does Inari Medical stock pay dividends?
No, Inari Medical (NARI) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Inari Medical dividend payment date?
Inari Medical (NARI) stock does not pay dividends to its shareholders.
What is the beta indicator for Inari Medical?
Inari Medical (NARI) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Inari Medical stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.